1. Home
  2. BWAY vs PCYO Comparison

BWAY vs PCYO Comparison

Compare BWAY & PCYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BWAY
  • PCYO
  • Stock Information
  • Founded
  • BWAY 2003
  • PCYO 1976
  • Country
  • BWAY Israel
  • PCYO United States
  • Employees
  • BWAY N/A
  • PCYO N/A
  • Industry
  • BWAY Medical/Dental Instruments
  • PCYO Water Supply
  • Sector
  • BWAY Health Care
  • PCYO Utilities
  • Exchange
  • BWAY Nasdaq
  • PCYO Nasdaq
  • Market Cap
  • BWAY 280.7M
  • PCYO 267.7M
  • IPO Year
  • BWAY 2019
  • PCYO N/A
  • Fundamental
  • Price
  • BWAY $15.44
  • PCYO $11.22
  • Analyst Decision
  • BWAY Strong Buy
  • PCYO
  • Analyst Count
  • BWAY 2
  • PCYO 0
  • Target Price
  • BWAY $20.50
  • PCYO N/A
  • AVG Volume (30 Days)
  • BWAY 65.4K
  • PCYO 51.3K
  • Earning Date
  • BWAY 11-11-2025
  • PCYO 11-12-2025
  • Dividend Yield
  • BWAY N/A
  • PCYO N/A
  • EPS Growth
  • BWAY 213.09
  • PCYO 12.50
  • EPS
  • BWAY 0.13
  • PCYO 0.54
  • Revenue
  • BWAY $49,094,000.00
  • PCYO $26,087,000.00
  • Revenue This Year
  • BWAY N/A
  • PCYO N/A
  • Revenue Next Year
  • BWAY N/A
  • PCYO N/A
  • P/E Ratio
  • BWAY $47.75
  • PCYO $20.39
  • Revenue Growth
  • BWAY 27.08
  • PCYO N/A
  • 52 Week Low
  • BWAY $7.84
  • PCYO $9.65
  • 52 Week High
  • BWAY $17.92
  • PCYO $14.63
  • Technical
  • Relative Strength Index (RSI)
  • BWAY 48.93
  • PCYO 60.70
  • Support Level
  • BWAY $14.27
  • PCYO $10.73
  • Resistance Level
  • BWAY $15.56
  • PCYO $11.22
  • Average True Range (ATR)
  • BWAY 0.82
  • PCYO 0.23
  • MACD
  • BWAY -0.10
  • PCYO 0.01
  • Stochastic Oscillator
  • BWAY 51.44
  • PCYO 68.59

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About PCYO Pure Cycle Corporation

Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.

Share on Social Networks: